Joo Ern’s main research interests have been in the development of early phase clinical trials and biomarkers with a focus on gynaecological cancers including ovarian cancer.
July 15, 2020
Joo Ern’s main research interests have been in the development of early phase clinical trials and biomarkers with a focus on gynaecological cancers including ovarian cancer.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
